Q3 2023 Holdings
Filed 2023-11-14 | 52 holdings | $323.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Laboratory Corp Amer Hldgs | COM NEW | 50540R409 | $33.9M | 168,809 | 10.5% |
| Globus MED Inc(GMED) | CL A | 379577208 | $25.7M | 516,981 | 7.9% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $18.5M | 509,000 | 5.7% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $18.4M | 81,606 | 5.7% |
| The Cigna Group(CI) | COM | 125523100 | $16.7M | 58,226 | 5.2% |
| GE Healthcare Technologies I(GEHC) | COMMON STOCK | 36266G107 | $16.5M | 242,308 | 5.1% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $16.0M | 796,933 | 5.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $14.9M | 450,700 | 4.6% |
| Organon & Co(OGN) | COMMON STOCK | 68622V106 | $13.3M | 767,000 | 4.1% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $12.7M | 64,491 | 3.9% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $12.6M | 15,250 | 3.9% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $8.7M | 110,780 | 2.7% |
| Embecta Corp(EMBC) | COMMON STOCK | 29082K105 | $8.6M | 568,294 | 2.6% |
| Healthcare Svcs Group Inc(HCSG) | COM | 421906108 | $8.5M | 810,307 | 2.6% |
| Orthofix MED Inc(OFIX) | COM | 68752M108 | $8.4M | 650,000 | 2.6% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $8.2M | 73,400 | 2.5% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $7.9M | 884,770 | 2.4% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $6.6M | 595,002 | 2.0% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $6.0M | 2,081,216 | 1.9% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $5.9M | 222,947 | 1.8% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $4.9M | 756,891 | 1.5% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $4.2M | 1,105,911 | 1.3% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $4.1M | 248,127 | 1.3% |
| Karuna Therapeutics Inc | COM | 48576A100 | $4.1M | 24,129 | 1.3% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $3.9M | 342,477 | 1.2% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $3.7M | 232,751 | 1.1% |
| Merrimack Pharmaceuticals in(MACKEUR) | COM NEW | 590328209 | $3.6M | 288,466 | 1.1% |
| Savara Inc(SVRA) | COM | 805111101 | $3.4M | 896,250 | 1.0% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $3.4M | 635,969 | 1.0% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $3.0M | 3,294,534 | 0.9% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $2.8M | 2,599,003 | 0.9% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $2.0M | 72,700 | 0.6% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $2.0M | 74,007 | 0.6% |
| Nyxoah SA(NYXH) | SHS | B6S7WD106 | $1.4M | 200,076 | 0.4% |
| Aprea Therapeutics Inc(APRE) | COM NEW | 03836J201 | $1.2M | 280,000 | 0.4% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $1.1M | 350,000 | 0.3% |
| Corbus Pharmaceuticals Hldgs Inc(CRBP) | COM NEW | 21833P301 | $1.0M | 150,000 | 0.3% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $918.7K | 76,049 | 0.3% |
| Sight Sciences Inc(SGHT) | COM | 82657M105 | $831.4K | 246,699 | 0.3% |
| Modular MED Inc(MODD) | COM NEW | 60785L207 | $799.6K | 689,352 | 0.2% |
| Harpoon Therapeutics Inc | COM NEW | 41358P205 | $677.1K | 168,017 | 0.2% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $639.7K | 246,036 | 0.2% |
| Aslan Pharmaceuticals LTD | SPON ADS NEW | 04522R200 | $477.8K | 254,150 | 0.1% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $421.7K | 97,616 | 0.1% |
| Inogen Inc(INGN) | COM | 45780L104 | $275.6K | 52,794 | 0.1% |
| Nextcure Inc | COM | 65343E108 | $167.7K | 130,000 | 0.1% |
| Moleculin Biotech Inc | COM | 60855D200 | $116.0K | 271,230 | 0.0% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $103.1K | 102,049 | 0.0% |
| Rocket Pharmaceuticals Inc | *W EXP 09/02/202 | 77313F114 | $69.8K | 400,000 | 0.0% |
| Caremax Inc | COM CL A | 14171W103 | $65.2K | 30,741 | 0.0% |